Biogen (BIIB)

Other Income/Expenses (Net)

-$415.90M

TTM · Period ending: · USD

BIIB logo

BIIB Other Income/Expenses (Net)

Latest reported-$415.90M
BIIB TTM Other Income/Expenses (Net) ($29.20M → -$415.90M)
High-resolution chart · PNG

BIIB other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biogen Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
-415,900,000
-74,300,000
-476,000,000
-539,500,000
-609,200,000
-432,900,000
-237,100,000
-240,400,000
-576,200,000
-890,000,000
-800,500,000
-534,200,000
428,900,000
749,500,000
705,300,000
575,600,000
-432,900,000
-626,300,000
-971,100,000
-185,400,000
180,300,000
112,800,000
502,600,000
-260,800,000
-168,200,000
-460,000,000
3,900,000
37,200,000
201,400,000
380,600,000
11,000,000
-26,800,000
-185,900,000
-220,000,000
-217,000,000
-198,600,000
-212,700,000
-202,600,000
-217,400,000
-251,800,000
-215,900,000
-173,200,000
-136,300,000
-62,838,000
-62,322,000
-43,594,000
-40,900,000
-42,321,000
-31,447,000
-36,610,000
-38,898,000
-34,134,000
-7,670,000
-2,485,000
28,153,000
29,775,000
6,394,000
-8,284,000
-13,477,000
-14,169,000
-13,387,000
-647,000
-18,984,000
-7,953,000
8,352,000
22,020,000
37,252,000
-3,964,000
-37,037,000
-55,735,000
-59,501,000
7,980,000
76,597,000
112,201,000
130,823,000
87,545,000
64,960,000
55,180,000
52,143,000
74,627,000
63,500,000
47,745,000
20,154,000
12,428,000
-337,000
25,000
20,677,000
-6,945,000
-3,386,000
-6,546,000
-14,962,000
-16,166,000
-28,611,000
-23,760,000
-20,042,000
-4,171,000
16,435,000
19,864,000
29,299,000
47,927,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.